The effects of potential neuroprotective agents on rat facial function recovery following facial nerve injury

Otolaryngology - Head and Neck Surgery

Volumn 144, Issue 1, 2011, Pages 53-59

  Vakharia, Kalpesh T ^a   Lindsay, Robin W ^b   Knox, Christopher ^a   Edwards, Colin ^a   Henstrom, Doug ^a   Weinberg, Julie ^a   Hadlock, Tessa A ^a   Heaton, James T ^c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Atorvastatin; Darbepoetin; Facial nerve crush injury; Facial paralysis; Sildenafil

Indexed keywords

ATORVASTATIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; SILDENAFIL; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; CONVALESCENCE; DRUG DOSE TITRATION; FACIAL NERVE INJURY; FEMALE; NERVE CRUSH; NEUROPROTECTION; NONHUMAN; RANDOMIZATION; RAT; TERTIARY HEALTH CARE; ANIMAL; COMPARATIVE STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; FACE MUSCLE; FACIAL NERVE; INNERVATION; PATHOPHYSIOLOGY; PHYSIOLOGY; TIME; WISTAR RAT;

ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FACIAL MUSCLES; FACIAL NERVE; FACIAL NERVE INJURIES; FEMALE; NEUROPROTECTIVE AGENTS; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; TIME FACTORS;

EID: 79959580746     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599810390892     Document Type: Article

References (30)

1. Heaton JT, Kowaleski JM, Bermejo R, et al. A system for studying facial nerve function in rats through simultaneous bilateral monitoring of eyelid and whisker movements. J Neurosci Methods. 2008;171:197-206.
2. Lindsay RW, Heaton JT, Edwards C, Smitson C, Hadlock TA. Nimodipine and acceleration of functional recovery of the facial nerve after crush injury. Arch Facial Plast Surg. 2010;12:49-52.
3. Reinecke K, Lucius R, Reinecke A, Rickert U, Herdegen T, Unger T. Angiotensin II accelerates functional recovery in the rat sciatic nerve in vivo: role of the AT2 receptor and the transcription factor NF-kappaB. Faseb J. 2003;17:2094-2096.
4. Yeh C, Bowers D, Hadlock TA. Effect of FK506 on functional recovery after facial nerve injury in the rat. Arch Facial Plast Surg. 2007;9:333-339.
5. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med. 1998;339:1349-1357.
6. Chen J, Zhang C, Jiang H, et al. Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice. J Cereb Blood Flow Metab. 2005;25:281-290. (Pubitemid 40171209)
7. Gholami MR, Abolhassani F, Pasbakhsh P, et al. The effects of simvastatin on ischemia-reperfusion injury of sciatic nerve in adult rats. Eur J Pharmacol. 2008;590:111-114.
8. Corbin JD, Francis SH. Cyclic GMP phosphodiesterase-5: target of sildenafil. J Biol Chem. 1999;274:13729-13732.
9. Hindley S, Juurlink BH, Gysbers JW, Middlemiss PJ, Herman MA, Rathbone MP. Nitric oxide donors enhance neurotrophin-induced neurite outgrowth through a cGMP-dependent mechanism. J Neurosci Res. 1997;47:427-439. (Pubitemid 27097757)
10. Gonzalez-Hernandez T, Rustioni A. Nitric oxide synthase and growth-associated protein are coexpressed in primary sensory neurons after peripheral injury. J Comp Neurol. 1999;404:64-74. (Pubitemid 29021519)
11. Zhang R, Zhang L, Zhang Z, et al. A nitric oxide donor induces neurogenesis and reduces functional deficits after stroke in rats. Ann Neurol. 2001;50:602-611. (Pubitemid 33021918)
12. Lykissas MG, Korompilias AV, Vekris MD, Mitsionis GI, Sakellariou E, Beris AE. The role of erythropoietin in central and peripheral nerve injury. Clin Neurol Neurosurg. 2007;109:639-644. (Pubitemid 47248036)
13. Campana WM, Myers RR. Erythropoietin and erythropoietin receptors in the peripheral nervous system: changes after nerve injury. Faseb J. 2001;15:1804-1806.
14. Grasso G, Meli F, Fodale V, Calapai G, Buemi M, Iacopino DG. Neuroprotective potential of erythropoietin and darbepoetin alfa in an experimental model of sciatic nerve injury: laboratory investigation. J Neurosurg Spine. 2007;7:645-651. (Pubitemid 350291549)
15. Allaf ME, Hoke A, Burnett AL. Erythropoietin promotes the recovery of erectile function following cavernous nerve injury. J Urol. 2005;174:2060-2064. (Pubitemid 41547024)
16. Hadlock T, Kowaleski J, Lo D, et al. Functional assessments of the rodent facial nerve: a synkinesis model. Laryngoscope. 2008;118:1744-1749.
17. Bridge PM, Ball DJ, Mackinnon SE, et al. Nerve crush injuries: a model for axonotmesis. Exp Neurol. 1994;127:284-290. (Pubitemid 24247972)
18. Zhang R, Wang Y, Zhang L, et al. Sildenafil (Viagra) induces neurogenesis and promotes functional recovery after stroke in rats. Stroke. 2002;33:2675-2680. (Pubitemid 35266440)
19. Sun W, Sun C, Lin H, et al. The effect of collagen-binding NGF-beta on the promotion of sciatic nerve regeneration in a rat sciatic nerve crush injury model. Biomaterials. 2009;30:4649-4656.
20. Zhang JY, Luo XG, Xian CJ, Liu ZH, Zhou XF. Endogenous BDNF is required for myelination and regeneration of injured sciatic nerve in rodents. Eur J Neurosci. 2000;12:4171-4180. (Pubitemid 32037828)
21. Fawcett JW, Keynes RJ. Peripheral nerve regeneration. Annu Rev Neurosci. 1990;13:43-60. (Pubitemid 20100640)
22. Hoogeveen JF, Troost D, Wondergem J, Kracht AHW, Haveman J. Hyperthermic injury versus crush injury in the rat sciatic nerve: a comparative functional, histopathological and morphometrical study. J Neurol Sci. 1992;108:55-64.
23. Gertz K, Laufs U, Lindauer U, et al. Withdrawal of statin treatment abrogates stroke protection in mice. Stroke. 2003;34:551-557. (Pubitemid 36206363)
24. Laufs U, Gertz K, Huang P, et al. Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke. 2000;31:2442-2449.
25. Holmberg E, Nordstrom T, Gross M, Kluge B, Zhang SX, Doolen S. Simvastatin promotes neurite outgrowth in the presence of inhibitory molecules found in central nervous system injury. J Neurotrauma. 2006;23:1366-1378. (Pubitemid 46489622)
26. Gholami M, Abolhassani F, Pasbakhsh P, et al. The effects of simvastatin on functional recovery of rat reperfused sciatic nerve. Pakistan J Biol Sci. 2007;10:4256-4260. (Pubitemid 350158590)
27. Egrie JC, Dwyer E, Browne JK, Hitz A, Lykos MA. Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin. Exp Hematol. 2003;31:290-299. (Pubitemid 36407605)
28. Patton J, Reeves T, Wallace J. Effectiveness of darbepoetin alfa versus epoetin alfa in patients with chemotherapy-induced anemia treated in clinical practice. Oncologist. 2004;9: 451-458. (Pubitemid 39014556)
29. Keswani SC, Buldanlioglu U, Fischer A, et al. A novel endogenous erythropoietin mediated pathway prevents axonal degeneration. Ann Neurol. 2004;56:815-826. (Pubitemid 39578445)
30. Zhang W, Sun B, Yu Z, An J, Liu Q, Ren T. High dose erythropoietin promotes functional recovery of rats following facial nerve crush. J Clin Neurosci. 2009;16:554-556.